Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

CONTEXT: Immunization with a meningococcal tetravalent (serogroup ACWY) glycoconjugate vaccine is recommended for all US adolescents. However, the currently licensed vaccine is poorly immunogenic in infancy, when the highest rates of disease are observed. OBJECTIVE: To determine the immunogenicity o...

Full description

Bibliographic Details
Main Authors:	Snape, MD, Perrett, K, Ford, K, John, T, Pace, D, Yu, L, Langley, J, McNeil, S, Dull, P, Ceddia, F, Anemona, A, Halperin, SA, Dobson, S, Pollard, A
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
by: Perrett, K, et al.
Published: (2009)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
by: Snape, MD, et al.
Published: (2009)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
by: Snape, MD, et al.
Published: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
by: Snape, M, et al.
Published: (2013)

Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.
by: Collins, C, et al.
Published: (2005)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
by: Khatami, A, et al.
Published: (2012)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
by: Khatami, A, et al.
Published: (2012)

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
by: Pace, D, et al.
Published: (2016)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
by: Read, R, et al.
Published: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
by: Read, R, et al.
Published: (2014)

Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial.
by: Buttery, J, et al.
Published: (2005)

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
by: Gossger, N, et al.
Published: (2012)

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
by: Micoli, F, et al.
Published: (2013)

A randomized trial assessing the immunogenicity and reactogenicity of two hexavalent infant vaccines concomitantly administered with group b meningococcal vaccine
by: Rajan, M, et al.
Published: (2022)

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda
by: Guerin, P, et al.
Published: (2008)

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine
by: Weissmueller, N, et al.
Published: (2017)

Quadrivalent meningococcal conjugate vaccines
by: Pace, D, et al.
Published: (2009)

Quadrivalent meningococcal conjugate vaccines.
by: Pace, D, et al.
Published: (2009)

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
by: Pace, D, et al.
Published: (2015)

Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005)

Immunogenicity and reactogenicity of a reduced schedule of a 4-component capsular group B meningococcal vaccine: a randomized controlled trial in infants
by: Valente Pinto, M, et al.
Published: (2020)

Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function
by: Martinón-Torres, FL, et al.
Published: (2018)

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
by: Snape, MD, et al.
Published: (2006)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
by: Snape, M, et al.
Published: (2006)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.
by: Kelly, D, et al.
Published: (2009)

Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.
by: Ramasamy, M, et al.
Published: (2014)

Use of fractional dose tetravalent A, C, W135 and Y meningococcal polysaccharide vaccine: A non inferiority trial
by: Guerin, P, et al.
Published: (2006)

Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against salmonella typhimurium and salmonella enteritidis.
by: Fiorino, F, et al.
Published: (2017)

The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.
by: Arcuri, M, et al.
Published: (2017)

The challenge of post-implementation surveillance for novel meningococcal vaccines.
by: Snape, MD, et al.
Published: (2012)

Recent advances in lipopolysaccharide-based glycoconjugate vaccines
by: Zhu, H, et al.
Published: (2021)

Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines
by: MacLennan, C, et al.
Published: (2016)

Four component meningococcal capsular Group B vaccine in preterm infants.
by: Sadarangani, M, et al.
Published: (2017)

Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
by: Micoli, F, et al.
Published: (2018)

Sugar-protein connectivity impacts on the immunogenicity of site-selective salmonella O-antigen glycoconjugate vaccines
by: Stefanetti, G, et al.
Published: (2010)

Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
by: Khatami, A, et al.
Published: (2011)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine (vol 127, pg 134, 2009)
by: Kelly, D, et al.
Published: (2011)

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
by: Snape, MD, et al.
Published: (2010)

Meningococcal vaccines.
by: Rüggeberg, J, et al.
Published: (2004)

Meningococcal vaccines.
by: Bethell, D, et al.
Published: (2002)